IGF-1 LR3
1mg
Institutional GradeIGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetically modified analog of native human IGF-1. This 83-amino acid peptide is structurally distinguished by a glutamate-to-arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications markedly reduce binding affinity to insulin-like growth factor binding proteins (IGFBPs), resulting in significantly extended biological activity and half-life in comparison to native IGF-1.
Lab Reports in Gallery
Swipe the product image above to view test reports for this batch.
Institutional Notice: This compound is synthesized and validated for laboratory research purposes only. Not for human consumption. By proceeding with order, you acknowledge status as a qualified researcher within a professional environment. All synthesis protocols adhere to strict laboratory oversight.
Full Lab Breakdown.
Purity, endotoxin, and heavy metals reports for the current production batch — all tests viewable inline.
Analytical Validation
Batch-specific third-party analytical testing performed to verify identity and purity via high-performance liquid chromatography (HPLC), with additional screening for bacterial endotoxins and heavy metals.
The Certificate of Analysis (COA) above applies exclusively to the batch listed and reflects analytical results obtained from the submitted sample. Endotoxin testing does not constitute sterility testing. Products are intended for research use only.